We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Natera, Inc., a global leader in cell-free DNA testing, and Neon Therapeutics, Inc., a clinical-stage immuno-oncology company developing neoantigen-based therapeutics.....
Business Wire Cambridge, Mass., Has successfully completed an extension of $ 36 million in Series B financing, plus the $ 70 million announced. In January 2017, the total funding for this round B transaction reached $ 106 million.